Bank of Montreal Can increases position in EndoChoice by 25.5%: 4 points

Bank of Montreal Can increased its stake in EndoChoice by 25.5 percent, according to a report by The Vista Voice.

Advertisement

Here are four points:

1. Bank of Montreal Can owned 2.29 percent of EndoChoice worth $4.73 million as of its most recent filing with the SEC.

2. The stock has a 50-day moving average price of $5.00 and a 200-day moving average price of $7.44.

3. EndoChoice has a 12-month low of $3.70 and a 12-month high of $19.69.

4. The company’s market capitalization is $133.4 million.

More articles on GI/endoscopy:
ACA, Medicare, ACOs & more: 5 things to know on gastroenterologist pay
5 most read GI/endoscopy stories: April 11 – April 15
NanoAntibiotics acquires company developing medicines for liver cirrhosis complications: 5 notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.